Kramer-Pollnow Award 2027 

Applications are welcome for basic research (e.g. genetics, imaging), translational research and research with a clinical focus. Research on the integration of innovative approaches such as digital health applications into the multimodal therapy of ADHD is also welcome. Contributions by psychiatrists, psychologists and other disciplines in an early (researchers who defended their first PhD no more than seven years ago and have provided proof of independent research) to middle (researchers who defended their first PhD more than 7 years ago but not more than 19 years ago) career stage are most appreciated.

The award is endowed with 6.000 Euro. The sponsor of the prize is the Germany-based pharmaceutical company MEDICE Arzneimittel Pütter GmbH & Co. KG, Iserlohn.

Required for the application are two to three original publications (published or in press) for the years 2025 – 2027 in peer-reviewed journals, a Curriculum Vitae as well as a list of previous publications. A specification of the contribution to the publications is also required.

Contributions are to be send to the Chair of the Board of Jurors, Prof. Dr. Dr. Tobias Banaschewski, Medical Director and Deputy Director, Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University.

^{The name of the award is based on the publication of Franz Kramer (1878-1967) and Hans Pollnow (1902-1943) from 1932: “Über eine hyperkinetische Erkrankung im Kindesalter” (“A hyperkinetic disorder in childhood”) which resembled behaviorally today´s ADHD. Kramer and Pollnow were medical doctors and worked both as neuropsychiatrists at the Charité University Hospital in Berlin in the 1930s. At that time, as Jews, they had to emigrate. Kramer then worked in the Netherlands where he died in 1967, while Pollnow was finally killed in the Concentration Camp of Mauthausen.}